Fractionated stereotactic radiotherapy of vestibular schwannomas accelerates hearing loss
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
To evaluate long-term tumor control and hearing preservation rates in patients with vestibular schwannoma treated with fractionated stereotactic radiotherapy (FSRT), comparing hearing preservation rates to an untreated control group. The relationship between radiation dose to the cochlea and hearing preservation was also investigated.
Originalsprog | Engelsk |
---|---|
Tidsskrift | International Journal of Radiation Oncology, Biology, Physics |
Vol/bind | 83 |
Udgave nummer | 5 |
Sider (fra-til) | e607-11 |
ISSN | 0360-3016 |
DOI | |
Status | Udgivet - 2012 |
ID: 48483250